Galapagos NV (formerly known as Galapagos Genomics) is a European pharmaceutical research company which was founded in 1999.

The company develops drugs against rheumatoid arthritis, crohn’s disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis.